Premium accounts now available! Sign up and create a premium account. Read more Close

Advertisement

Image

Revised Adaptive Immune Receptor Data in the Immune Epitope Database

Preprint Created on 06 Jun 2026 bioRxiv

The Immune Epitope Database (IEDB, iedb.org) is a freely available resource that catalogs experimentally defined immune epitopes and - if available - the immune receptors that recognize them. Currently, the IEDB records ~185,000 T cell receptors and ~5,000 B cell receptors/antibodies with experimentally verified epitope specificity. Because these receptor data were manually curated from ~3,300 references spanning decades, nomenclature inconsistencies present challenges for computational analyses and user queries. To support integrated analysis of the entire dataset, we revised the IEDB receptor data standardization and validation pipeline to flag and correct inaccuracies. Anomalous receptors from over 800 studies were flagged for re-curation. The updated receptor dataset shows greater conformity through consistent gene nomenclature formatting and harmonized CDR sequence delimitation. Taking advantage of the increased receptor data consistency, the IEDB web interface was expanded to include receptor search features directly on the homepage, support V/J gene and species options in the refined receptor search, and allow direct data export in the Adaptive Immune Receptor Repertoire (AIRR) format. We anticipate that the improved receptor data quality will simplify bioinformatics analyses, and facilitate integration of IEDB data into cross-repository data resources, such as the AIRR Knowledge Commons.

Scheffer, L., Richardson, E. M., Vita, R., Zarebski, L., Blazeska, N., Wheeler, D. K., Cantrell, J. R., Deleuran, S. N., Lees, W. D., Christley, S., Corrie, B., Cowell, L. G., Sette, A., Peters, B.

Advertisement

Stats

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement